{
    "ucits": true,
    "type": "ETF",
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": false,
    "replication_method": "synthetic",
    "complex_factors": "Leverage, Synthetic replication using total return swaps, Embedded derivatives, Complex structured products exposure (leveraged index), Counterparty and collateral risk",
    "classification": "complex",
    "supporting_data": "The asset is a UCITS ETF, which generally presumes non-complexity under MiFID II. However, this ETF tracks the FTSE 100 Daily Leveraged Index with a 2x daily leverage factor, achieved primarily through total return swap agreements with swap counterparties. The use of swaps as the core replication method introduces counterparty and collateral risks, which are difficult for retail investors to understand, making the ETF synthetic and complex. The ETF's objective to deliver twice the daily performance of the underlying index involves daily rebalancing and compounding effects, adding to complexity. The presence of leverage beyond normal UCITS borrowing limits (daily 2x leverage) further contributes to complexity. According to MiFID II Article 254 and Delegated Regulation EU 2017/565 Article 57, such derivative use integral to the investment objective, synthetic replication, and leverage classify the ETF as complex. The ETF does not use derivatives solely for efficient portfolio management but as an inherent element of its strategy. The complexity is reinforced by the need for retail investors to understand advanced concepts such as swaps, counterparty risk, and the impact of daily leverage reset and compounding. Therefore, despite being UCITS, the ETF is complex and requires an appropriateness assessment under MiFID II. This aligns with ESMA guidance that synthetic and leveraged UCITS ETFs are complex products requiring investor protection measures. No evidence suggests the ETF is non-complex or uses derivatives only for EPM. Hence, the classification is complex."
}